Korean J Intern Med.
2017 May;32(3):569-569. 10.3904/kjim.2017.137.
Comment on “New therapeutic agents in diabetic nephropathyâ€
- Affiliations
-
- 1Bayer AG, Berlin, Germany. alain.gay@bayer.com
- KMID: 2379493
- DOI: http://doi.org/10.3904/kjim.2017.137
Abstract
- No abstract available.
MeSH Terms
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Response to comment on “New therapeutic agents in diabetic nephropathyâ€
- The role of inflammation in diabetic kidney disease
- Reply to the Comment on Adoption of Artificial Intelligence, Preprints, Open Peer Review, Model Text Recycling Policies, Best Practice in Scholarly Publishing: Comment
- Glycemic Control in Diabetic Patients with Diabetic Nephropathy
- Recent Updates on Diabetic Nephropathy
